Human bone marrow activates the Akt pathway in metastatic prostate cells through transactivation of the alpha-platelet-derived growth factor receptor.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 17234763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells.

  2006cited by this paper
• The New Era in Cancer Research

  2006cited by this paper
• Transactivation of platelet-derived growth factor receptor alpha by the GTPase-deficient activated mutant of Galpha12.

  2006cited by this paper
• Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer

  2006cited by this paper
• Bone turnover mediates preferential localization of prostate cancer in the skeleton.

  2005cited by this paper
• Targeting the platelet-derived growth factor receptor α with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: Implications as a potential therapeutic target

  2005cited by this paper
• Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.

  2005cited by this paper
• Bone-metastatic potential of human prostate cancer cells correlates with Akt/PKB activation by α platelet-derived growth factor receptor

  2005cited by this paper
• PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

  2004cited by this paper
• Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo

  2004cited by this paper
• CX3CR1-Fractalkine Expression Regulates Cellular Mechanisms Involved in Adhesion, Migration, and Survival of Human Prostate Cancer Cells

  2004cited by this paper
• Targeting the PI3K-Akt pathway in human cancer: rationale and promise.

  2003cited by this paper
• Stromal factors involved in prostate carcinoma metastasis to bone

  2003cited by this paper
• Molecular mechanisms underlying osteoclast formation and activation.

  2003cited by this paper
• EGF receptor transactivation is obligatory for protein synthesis stimulation by G protein-coupled receptors.

  2002cited by this paper
• Cytoplasmic transport of Stat3 by receptor‐mediated endocytosis

  2002cited by this paper
• Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

  2001cited by this paper
• Activation of Trk neurotrophin receptors in the absence of neurotrophins

  2001cited by this paper
• Platelet-derived growth factor (PDGF)-AA: a self-imposed cytokine in the proliferation of human fetal osteoblasts.

  2000cited by this paper
• Specific inhibitors of platelet-derived growth factor or epidermal growth factor receptor tyrosine kinase reduce pulmonary fibrosis in rats.

  1999cited by this paper
• Mechanism of action and in vivo role of platelet-derived growth factor.

  1999cited by this paper
• Tyrosine kinases expressed in vivo by human prostate cancer bone marrow metastases and loss of the type 1 insulin-like growth factor receptor.

  1999cited by this paper
• Cellular survival: a play in three Akts.

  1999cited by this paper
• Ligand-independent activation of platelet-derived growth factor receptor is a necessary intermediate in lysophosphatidic, acid-stimulated mitogenic activity in L cells.

  1998cited by this paper
• Expression and growth factor regulation of platelet-derived growth factor B transcripts in primary osteoblast cell cultures.

  1996cited by this paper
• Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

  1996cited by this paper
• Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia

  1991cited by this paper
• Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S.C.I.D. mice.

  1991cited by this paper
• Establishment and characterization of a human prostatic carcinoma cell line (PC-3).

  1979cited by this paper

• Tumor Microenvironment in Prostate Cancer: Toward Identification of Novel Molecular Biomarkers for Diagnosis, Prognosis, and Therapy Development

  2021cites this paper
• AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review

  2021cites this paper
• Over-expression of JAZF1 promotes cardiac microvascular endothelial cell proliferation and angiogenesis via activation of the Akt signaling pathway in rats with myocardial ischemia-reperfusion

  2019cites this paper
• Developments in the management of advanced soft-tissue sarcoma – olaratumab in context

  2018cites this paper
• Angiogenesis biomarkers and their targeting ligands as potential targets for tumor angiogenesis

  2018cites this paper
• Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α

  2017cites this paper
• A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumors

  2017cites this paper
• EMERGING ROLES OF PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA IN CHRONIC LIVER INJURY: POTENTIAL THERAPEUTIC TARGET IN HEPATIC FIBROSIS

  2017cites this paper
• Vascular Endothelial Cell Growth Factor A Acts via Platelet-Derived Growth Factor Receptor α To Promote Viability of Cells Enduring Hypoxia

  2016cites this paper
• Pharmacological targeting of the PDGF-CC signaling pathway for blood-brain barrier restoration in neurological disorders.

  2016cites this paper
• Platelet Derived Growth Factor Has a Role in Pressure Induced Bladder Smooth Muscle Cell Hyperplasia and Acts in a Paracrine Way.

  2015cites this paper
• PDGFRα in liver pathophysiology: emerging roles in development, regeneration, fibrosis, and cancer.

  2015cites this paper
• Nilotinib in Combination with Carboplatin and Paclitaxel Is a Candidate for Ovarian Cancer Treatment

  2014cites this paper
• A phase I study of olaratumab, an anti-platelet-derived growth factor receptor alpha (PDGFRα) monoclonal antibody, in patients with advanced solid tumors

  2014cites this paper
• Is neutralizing vitreal growth factors a viable strategy to prevent proliferative vitreoretinopathy?

  2014influential citation
• Variable Metastatic Potentials Correlate with Differential Plectin and Vimentin Expression in Syngeneic Androgen Independent Prostate Cancer Cells

  2013cites this paper
• Targeting the PDGF signaling pathway in tumor treatment

  2013cites this paper
• Trial Watch: Monoclonal antibodies in cancer therapy

  2012cites this paper
• Pathological Signaling via Platelet-Derived Growth Factor Receptor α Involves Chronic Activation of Akt and Suppression of p53

  2011cites this paper
• PDGF induced microRNA alterations in cancer cells

  2011cites this paper
• The chemokine receptor CX3CR1 is directly involved in the arrest of breast cancer cells to the skeleton

  2011cites this paper
• The alpha-receptor for platelet-derived growth factor confers bone-metastatic potential to prostate cancer cells by ligand- and dimerization-independent mechanisms.

  2010cites this paper
• Targeting the α Receptor for Platelet-Derived Growth Factor as a Primary or Combination Therapy in a Preclinical Model of Prostate Cancer Skeletal Metastasis

  2010cites this paper
• Cancer: evolutionary, genetic and epigenetic aspects

  2010cites this paper
• Growth factors outside the PDGF family drive experimental PVR.

  2009cites this paper
• Carcinogenesis: Evolution of concepts

  2009cites this paper
• Growth Factors Outside of the Platelet-derived Growth Factor (PDGF) Family Employ Reactive Oxygen Species/Src Family Kinases to Activate PDGF Receptor α and Thereby Promote Proliferation and Survival of Cells*

  2009cites this paper
• The α-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells

  2009cites this paper
• Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells

  2009cites this paper
• Pharmacogenomic and mechanistic studies on dietary factors in chemoprevention of cancer

  2008cites this paper
• Interactions of Prostate Cancer Cells to Human Microvascular Endothelial Cells Under Shear Stress Conditions

  2007cites this paper
• Chinese Anti鄄 Cancer a Ssociation

  year unknowncites this paper